Gainers
- iRhythm Technologies IRTC stock rose 21.6% to $143.58 during Friday's pre-market session. The company's market cap stands at $4.2 billion. As per the news, the Q1 earnings report came out yesterday.
- Cue Biopharma CUE shares moved upwards by 14.99% to $4.6. The market value of their outstanding shares is at $162.7 million.
- Sensus Healthcare SRTS shares moved upwards by 11.73% to $8.0. The company's market cap stands at $133.4 million. As per the press release, Q1 earnings came out yesterday.
- LogicBio Therapeutics LOGC stock rose 10.85% to $0.61. The market value of their outstanding shares is at $20.1 million.
- AcelRx Pharmaceuticals ACRX stock increased by 8.77% to $0.23. The company's market cap stands at $33.5 million.
- ChemoCentryx CCXI shares increased by 8.69% to $17.0. The market value of their outstanding shares is at $1.2 billion. The company's, Q1 earnings came out yesterday.
Losers
- Endo International ENDP shares fell 38.1% to $1.25 during Friday's pre-market session. The company's market cap stands at $293.8 million. As per the press release, Q1 earnings came out yesterday.
- T2 Biosystems TTOO stock fell 18.71% to $0.31. The market value of their outstanding shares is at $53.5 million. As per the news, the Q1 earnings report came out yesterday.
- Kintara Therapeutics KTRA shares decreased by 10.48% to $0.19. The market value of their outstanding shares is at $12.4 million.
- Sonoma Pharmaceuticals SNOA shares decreased by 10.32% to $3.13. The market value of their outstanding shares is at $9.6 million.
- Monopar Therapeutics MNPR stock declined by 9.1% to $2.0. The market value of their outstanding shares is at $25.2 million.
- Vanda Pharmaceuticals VNDA stock fell 8.17% to $9.0. The market value of their outstanding shares is at $508.4 million. The company's, Q1 earnings came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in